- Home
- Publications
- Publication Search
- Publication Details
Title
The molecular basis of myeloid malignancies
Authors
Keywords
-
Journal
PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES
Volume 90, Issue 10, Pages 389-404
Publisher
Japan Academy
Online
2014-12-11
DOI
10.2183/pjab.90.389
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms
- (2014) P. Lundberg et al. BLOOD
- Proto-Oncogenic Role of Mutant IDH2 in Leukemia Initiation and Maintenance
- (2014) Lev M. Kats et al. Cell Stem Cell
- Patterns of missplicing due to somatic U2AF1 mutations in myeloid neoplasms
- (2013) B. Przychodzen et al. BLOOD
- RUNX1/AML1 mutant collaborates with BMI1 overexpression in the development of human and murine myelodysplastic syndromes
- (2013) Y. Harada et al. BLOOD
- The shortest isoform of C/EBP , liver inhibitory protein (LIP), collaborates with Evi1 to induce AML in a mouse BMT model
- (2013) N. Watanabe-Okochi et al. BLOOD
- A DNMT3A mutation common in AML exhibits dominant-negative effects in murine ES cells
- (2013) S. J. Kim et al. BLOOD
- Mutant IDH1 promotes leukemogenesis in vivo and can be specifically targeted in human AML
- (2013) A. Chaturvedi et al. BLOOD
- Loss of Asxl1 leads to myelodysplastic syndrome-like disease in mice
- (2013) J. Wang et al. BLOOD
- Clinical and biological implications of driver mutations in myelodysplastic syndromes
- (2013) E. Papaemmanuil et al. BLOOD
- Polycomb Repressive Complex 2 Regulates Normal Hematopoietic Stem Cell Function in a Developmental-Stage-Specific Manner
- (2013) Huafeng Xie et al. Cell Stem Cell
- Myelodysplastic syndromes are induced by histone methylation–altering ASXL1 mutations
- (2013) Daichi Inoue et al. JOURNAL OF CLINICAL INVESTIGATION
- SETBP1 mutation analysis in 944 patients with MDS and AML
- (2013) F Thol et al. LEUKEMIA
- Landscape of genetic lesions in 944 patients with myelodysplastic syndromes
- (2013) T Haferlach et al. LEUKEMIA
- Mutant DNMT3A: teaming up to transform
- (2012) C. Thiede BLOOD
- Setbp1 promotes the self-renewal of murine myeloid progenitors via activation of Hoxa9 and Hoxa10
- (2012) K. Oakley et al. BLOOD
- Knock-in of a FLT3/ITD mutation cooperates with a NUP98-HOXD13 fusion to generate acute myeloid leukemia in a mouse model
- (2012) S. Greenblatt et al. BLOOD
- ASXL1 Mutations Promote Myeloid Transformation through Loss of PRC2-Mediated Gene Repression
- (2012) Omar Abdel-Wahab et al. CANCER CELL
- Nucleophosmin/B26 regulates PTEN through interaction with HAUSP in acute myeloid leukemia
- (2012) N I Noguera et al. LEUKEMIA
- IDH1(R132H) mutation increases murine haematopoietic progenitors and alters epigenetics
- (2012) Masato Sasaki et al. NATURE
- Development of a Multi-Step Leukemogenesis Model of MLL-Rearranged Leukemia Using Humanized Mice
- (2012) Kunihiko Moriya et al. PLoS One
- R723, a selective JAK2 inhibitor, effectively treats JAK2V617F-induced murine myeloproliferative neoplasm
- (2011) K. Shide et al. BLOOD
- Distinct classes of c-Kit-activating mutations differ in their ability to promote RUNX1-ETO-associated acute myeloid leukemia
- (2011) H. J. Nick et al. BLOOD
- Evi1 represses PTEN expression and activates PI3K/AKT/mTOR via interactions with polycomb proteins
- (2011) A. Yoshimi et al. BLOOD
- TET2 Inactivation Results in Pleiotropic Hematopoietic Abnormalities in Mouse and Is a Recurrent Event during Human Lymphomagenesis
- (2011) Cyril Quivoron et al. CANCER CELL
- The Spliceosome as an Indicted Conspirator in Myeloid Malignancies
- (2011) Omar Abdel-Wahab et al. CANCER CELL
- Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent Dioxygenases
- (2011) Wei Xu et al. CANCER CELL
- MLL-Rearranged Leukemia Is Dependent on Aberrant H3K79 Methylation by DOT1L
- (2011) Kathrin M. Bernt et al. CANCER CELL
- Tet2 Loss Leads to Increased Hematopoietic Stem Cell Self-Renewal and Myeloid Transformation
- (2011) Kelly Moran-Crusio et al. CANCER CELL
- Frequent pathway mutations of splicing machinery in myelodysplasia
- (2011) Kenichi Yoshida et al. NATURE
- Two types of C/EBP mutations play distinct but collaborative roles in leukemogenesis: lessons from clinical data and BMT models
- (2010) N. Kato et al. BLOOD
- Combined mutations of ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2 and WT1 genes in myelodysplastic syndromes and acute myeloid leukemias
- (2010) Julien Rocquain et al. BMC CANCER
- Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation
- (2010) Maria E. Figueroa et al. CANCER CELL
- Chronic myeloid leukemia: mechanisms of blastic transformation
- (2010) Danilo Perrotti et al. JOURNAL OF CLINICAL INVESTIGATION
- Regulation of myeloid leukaemia by the cell-fate determinant Musashi
- (2010) Takahiro Ito et al. NATURE
- Therapeutic targeting of MLL
- (2009) M. Liedtke et al. BLOOD
- Hes1 immortalizes committed progenitors and plays a role in blast crisis transition in chronic myelogenous leukemia
- (2009) F. Nakahara et al. BLOOD
- Mutations of polycomb-associated geneASXL1in myelodysplastic syndromes and chronic myelomonocytic leukaemia
- (2009) Véronique Gelsi-Boyer et al. BRITISH JOURNAL OF HAEMATOLOGY
- Hematopoietic Stem Cell Expansion Precedes the Generation of Committed Myeloid Leukemia-Initiating Cells in C/EBPα Mutant AML
- (2009) Oxana Bereshchenko et al. CANCER CELL
- Mixed-lineage-leukemia (MLL) fusion protein collaborates with Ras to induce acute leukemia through aberrant Hox expression and Raf activation
- (2009) R Ono et al. LEUKEMIA
- AML1 mutations induced MDS and MDS/AML in a mouse BMT model
- (2008) N. Watanabe-Okochi et al. BLOOD
- Menin Critically Links MLL Proteins with LEDGF on Cancer-Associated Target Genes
- (2008) Akihiko Yokoyama et al. CANCER CELL
- Ratio of mutant JAK2-V617F to wild-type Jak2 determines the MPD phenotypes in transgenic mice
- (2007) R. Tiedt et al. BLOOD
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started